Get the Stockscreener App
8.9708
0.90%
0.0708
Anavex Life Sciences Corporation stock is traded at $8.9708, with a volume of 171.67K.
It is up +0.90% in the last 24 hours and up +6.02% over the past month.
Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are further used in the analysis of clinical trials. The company's focus is on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its various therapeutic candidates in different stages of development include Anavex 2-73 (Blacamesine), Anavex 3-71 (AF710B), Anavex 1-41, and Anavex 1066.
See More
Previous Close:
$8.90
Open:
$8.85
24h Volume:
171.67K
Relative Volume:
0.11
Market Cap:
$751.12M
Revenue:
-
Net Income/Loss:
$-43.16M
P/E Ratio:
-16.31
EPS:
-0.55
Net Cash Flow:
$-29.31M
1W Performance:
+4.54%
1M Performance:
+6.02%
6M Performance:
+69.11%
1Y Performance:
+66.91%
1-Day Range:
$8.8001
$9.20
1-Week Range:
$8.37
$9.25
52-Week Range:
$3.25
$14.44
Anavex Life Sciences Corporation Stock (AVXL) Company Profile
Name
Anavex Life Sciences Corporation
Sector
Industry
Phone
844-689-3939
Address
630 5TH AVENUE, NEW YORK
Compare AVXL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AVXL
Anavex Life Sciences Corporation
|
8.98 | 751.12M | 0 | -43.16M | -29.31M | -0.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
502.81 | 130.96B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
684.98 | 75.53B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
578.98 | 35.07B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
242.67 | 31.72B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
250.16 | 26.76B | 3.32B | -860.46M | -1.04B | -8.32 |
Anavex Life Sciences Corporation Stock (AVXL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-06-22 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jun-23-22 | Initiated | Berenberg | Buy |
| Sep-23-21 | Initiated | BTIG Research | Buy |
| Dec-16-20 | Reiterated | H.C. Wainwright | Buy |
| Sep-28-20 | Initiated | Ladenburg Thalmann | Buy |
| Feb-27-20 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-18-19 | Initiated | Janney | Buy |
| May-16-18 | Resumed | Maxim Group | Buy |
| Mar-08-18 | Initiated | ROTH Capital | Buy |
| Feb-13-18 | Reiterated | Maxim Group | Buy |
| Sep-29-17 | Resumed | Noble Financial | Buy |
| Feb-07-17 | Initiated | Noble Financial | Buy |
| Mar-29-16 | Initiated | FBR Capital | Outperform |
View All
Anavex Life Sciences Corporation Stock (AVXL) Latest News
Proficio Capital Partners LLC Purchases New Holdings in Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Did Anavex Life Sciences Corp. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate- AVXL - ACCESS Newswire
Anavex Life Sciences Corp. to Host Earnings Call - ACCESS Newswire
Anavex Life Sciences Corp. (NASDAQ:AVXL) Stake Raised by Rhumbline Advisers - Defense World
Private Advisor Group LLC Sells 17,488 Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
IMMINENT AVXL DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Anavex Life Sciences Corp. Investors to Join the Class Action Lawsuit! - ACCESS Newswire
Y Intercept Hong Kong Ltd Makes New $243,000 Investment in Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Anavex Life Sciences Corporation Sued for Securities Law ViolationsContact Levi & Korsinsky Before May 13, 2024 to Discuss Your RightsAVXL - ACCESS Newswire
Levi & Korsinsky Reminds Anavex Life Sciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 13, 2024 – AVXL - ACCESS Newswire
Levi & Korsinsky Notifies Anavex Life Sciences Corporation Investors of a Class Action Lawsuit and Upcoming DeadlineAVXL - ACCESS Newswire
Class Action Filed Against Anavex Life Sciences Corporation (AVXL) Seeking Recovery for InvestorsContact Levi & Korsinsky - ACCESS Newswire
27,052 Shares in Anavex Life Sciences Corp. (NASDAQ:AVXL) Bought by Atria Wealth Solutions Inc. - Defense World
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Anavex Life Sciences Corporation(AVXL) Shareholders - ACCESS Newswire
AVXL LAWSUIT ALERT: Levi & Korsinsky Notifies Anavex Life Sciences Corporation Investors of a Class Action Lawsuit and Upcoming Deadline - ACCESS Newswire
D.A. Davidson & CO. Buys Shares of 11,385 Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Anavex Life Sciences Corp. Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm - ACCESS Newswire
Anavex Life Sciences Corporation Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before May 13, 2024 to Discuss Your RightsAVXL - ACCESS Newswire
Anavex Life Sciences Corp. (NASDAQ:AVXL) Is Expected To Breakeven In The Near Future - Yahoo Finance
Levi & Korsinsky Reminds Anavex Life Sciences Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 13, 2024AVXL - ACCESS Newswire
When Will Anavex Life Sciences Corp. (NASDAQ:AVXL) Breakeven? - Simply Wall St
Shareholders that lost money on Anavex Life Sciences Corporation (AVXL) should contact Levi & Korsinsky about pending Class ActionAVXL - ACCESS Newswire
Anavex Life Sciences to Present at the 45th Annual TD Cowen Health Care Conference - The Manila Times
Can Anavex's Neurology Pipeline Transform Alzheimer's Treatment? CEO Presents Latest Progress - StockTitan
Anavex Life Sciences (NASDAQ:AVXL) Earns Buy Rating from HC Wainwright - MarketBeat
Brokers Issue Forecasts for AVXL Q1 Earnings - Defense World
UPCOMING AVXL DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Anavex Life Sciences Corp. Investors to Join the Class Action Lawsuit! - ACCESS Newswire
AVXL SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Anavex Life Sciences Corp. Investors Can Join the Class Action Lawsuit - ACCESS Newswire
Anavex Life Sciences (NASDAQ:AVXL) Given “Buy” Rating at HC Wainwright - Defense World
Wainwright maintains $42 target on Anavex Life Sciences stock By Investing.com - Investing.com Nigeria
AVXL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Reminds Anavex Life Sciences Corp. Investors to Join the Class Action Lawsuit! - ACCESS Newswire
Lost Money on Anavex Life Sciences Corporation(AVXL)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - ACCESS Newswire
Wainwright maintains $42 target on Anavex Life Sciences stock - Investing.com
AVXL SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Reminds Anavex Life Sciences Corp. Investors to Join the Class Action Lawsuit! - ACCESS Newswire
Shareholders of Anavex Life Sciences Corporation Should Contact Levi & Korsinsky Before May 13, 2024 to Discuss Your RightsAVXL - ACCESS Newswire
Anavex Life Sciences (NASDAQ:AVXL) Posts Earnings Results, Beats Estimates By $0.03 EPS - MarketBeat
D. Boral Capital Reaffirms "Buy" Rating for Anavex Life Sciences (NASDAQ:AVXL) - MarketBeat
Earnings call transcript: Anavex Life Sciences Q4 2024 sees net loss, stock rises - MSN
Anavex: Looking At Different Statistical Approaches Before EMA Opinion (NASDAQ:AVXL) - Seeking Alpha
Anavex Life Sciences Corp. (NASDAQ:AVXL) Q1 2025 Earnings Call Transcript - MSN
Anavex Life Sciences Reports Higher Quarterly Loss Amid R&D Focus - TipRanks
Anavex Life Sciences: Fiscal Q1 Earnings Snapshot - mySA
Anavex Life Sciences Corp. (AVXL) reports earnings - Quartz
Anavex Life Sciences Corp. Reports Earnings Results for the First Quarter Ended December 31, 2024 - Marketscreener.com
Anavex Life Sciences Corporation Stock (AVXL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Anavex Life Sciences Corporation Stock (AVXL) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Thomas Steffen | Director |
May 15 '24 |
Buy |
4.52 |
5,000 |
22,600 |
5,000 |
| MISSLING CHRISTOPHER U | President and CEO |
Mar 28 '24 |
Option Exercise |
1.32 |
73,380 |
96,862 |
1,323,590 |
| MISSLING CHRISTOPHER U | President and CEO |
Mar 28 '24 |
Sale |
5.11 |
73,380 |
374,972 |
1,250,210 |
5.68%
0.28%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):